Table 4. Summarized the mixed model results (n = 1300)*.
Characteristic | Surgeon caseload | Hospital caseload | |||||||||||||
High- volume | Medium-volume | Low-volume | High-volume | Medium-volume | Low-volume | ||||||||||
β** | SE | Pvalue | β** | SE | Pvalue | β** | SE | Pvalue | β** | SE | Pvalue | ||||
Spending for oncological surgery | |||||||||||||||
Oncological surgery cost | reference | −43 | 458 | 0.925 | 845 | 390 | 0.030 | reference | 79 | 1670 | 0.963 | 1217 | 1520 | 0.430 | |
Spending for 12-month follow-up period | |||||||||||||||
OPD expenditure | reference | −383 | 543 | 0.482 | 198 | 472 | 0.676 | reference | −648 | 1085 | 0.557 | 1315 | 1002 | 0.204 | |
Hospitalization cost | reference | 1350.91 | 701 | 0.055 | 1251 | 623 | 0.045 | reference | 1584 | 1311 | 0.250 | 1810 | 1217 | 0.160 | |
Outpatient & hospitalization cost | reference | 1811 | 818 | 0.030 | 2065 | 763 | 0.007 | reference | 790 | 841 | 0.391 | 3439 | 836 | 0.004 |
SE, standard error.
Adjusted variables were the patients’ diagnosed age, gender, CCIS categories, urbanization and region of patients’ residence individual, socioeconomic status, surgeon’s age, and teaching level of hospitals.
Parameter estimate.